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Abstract
Dengue caused by four antigenically distinct serotype remains a serious health concern 
around the world, particularly in the tropical areas. Clinical signs and symptoms of this 
disease are indistinguishable from other infectious disease; therefore, laboratory diagno-
sis is very crucial for confirming the disease that will be useful for the patient’s manage-
ment. In laboratory, dengue can be confirmed using cell culture, RNA detection, and 
serological detection based on ELISA and immunochromatographic test. However, each 
of these methods has certain practical limitations. Therefore, researchers from all over the 
world have been working to address these limitations. In this chapter, we will highlight 
the current research toward the development of novel point-of-care test for the diagnosis 
of dengue in acute and convalescent phase.
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1. Introduction
Despite the significant advancement in medical sciences, dengue remains a serious public 
health concern in more than 100 countries, precisely in tropical and subtropical parts of 
the world. Dengue has alarming situation in Southeast Asia, South America, and Africa. 
Approximately, half of the world’s population living in dengue endemic area is at the risk of 
getting dengue infection. Evidence shows that every year about 390 million dengue infection 
appears worldwide, of which 100 million cases are found to be symptomatic and require 
medical attention [1–3].
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Clinical symptoms typically appear 4–7 days following the mosquito bite and may persist 
for 3–10 days. Clinical manifestation of dengue varies from asymptomatic to acute febrile 
illness with headache, vomiting, severe myalgia, rash, retro-orbital pain, and arthralgia [4–6]. 
Classically, dengue was categorized as dengue fever, dengue hemorrhagic fever, and dengue 
shock syndrome. Nevertheless, classification was revised by the WHO in 2009 and classified 
it as dengue with or without warning signs. This version of classification divides dengue into 
three clinical phases: febrile, critical, and recovery phases [7, 8]. In the febrile phase, patient 
develops high fever due to acute viremia, and this phase lasts for 2–7 days. Critical phase 
usually lasts for 2 days and is indicated by plasma leakage, hemorrhage, and low platelet 
number. If patients survive in critical phase, then they will recover from the disease at the 
third phase known as recovery/convalescent phase [9, 10].
The spherical and enveloped dengue virus (DENV) which belongs to the family Flaviviridae 
is the causative agent of dengue. This virus is 50 nm in diameter and contains about 11 kb 
positive-sense single-stranded RNA genome that codes for three structural proteins (capsid, 
membrane, and envelope) and seven nonstructural proteins [11, 12]. The DENV is transmitted 
to human by the bite of Aedes aegypti and Aedes albopictus mosquito which usually breed in 
the clean water in urban areas [13, 14]. Each serotype of DENV can cause dengue and trigger 
inimitable immune response in host which provides long-term immunity to that particular 
serotype but limited and partial immunity against three other serotypes [15, 16]. Although, 
the four DENV serotypes are antigenically different but genetically are identical as they share 
about 65% of their RNA sequences [17, 18].
2. Diagnosis of dengue
At this time, a tetravalent dengue vaccine has been developed but due to its lack of pro-
tection on non-exposed individuals, it is not an effective option. On the other hand, antivi-
ral drugs for curing the dengue are not available; thus, accurate and timely diagnosis is of 
utmost importance for appropriate management of a patient suffering from severe dengue 
[19]. However, diagnosis of dengue based on clinical manifestation is quite complicated as 
the signs of dengue are very common in other febrile illness; therefore, diagnosis is very 
challenging using this approach [10, 20]. Thus, laboratory confirmation is needed for defi-
nite diagnosis. Laboratory confirmation of dengue can be obtained using several techniques 
such as virus isolation, polymerase chain reaction (PCR)-based detection of viral genome, 
nonstructural protein 1 (NS1) antigen detection, and serological detection of dengue-specific 
antibodies such as IgM and IgG [21]. Nevertheless, effective application of each diagnostic 
technique depends on the disease stages.
2.1. Recent advancement in the diagnosis of dengue
The WHO set “affordable, sensitive, specific, user-friendly, rapid, easy to handle and deliver 
to those who need them (ASSURED)” as the characteristics of an ideal point-of-care test for 
resource-limited countries [22, 23]. With the advancement of science and technology, several 
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novel diagnostic platforms emerged for the diagnostic of infectious disease such as biosensor, 
microfluidic, loop-mediated isothermal amplification (LAMP), and so on. These diagnostic 
platforms were also explored by the researchers for developing a point-of-care test for the 
diagnosis of dengue. The below section will briefly give an insight into some of these plat-
forms investigated for the diagnosis of dengue.
2.1.1. Biosensor platform
The criteria of point-of-care test resulted attractive for industry and researchers in order to 
develop and satisfy the qualification of ideal diagnostic test. Therefore, numerous researchers 
around the world have been working on biosensors in a search of potential point-of-care test 
as they offer several advantages such as high sensitivity and specificity, simple instrumenta-
tion, rapid assay outcome, portability and disposability of developed tools. Several research-
ers have reported biosensor for the diagnosis of dengue. In this section, we take a glance 
over current biosensor methods aimed to improve the diagnostic of dengue using different 
biomarkers.
2.1.1.1. NS1 antigen detection
Omar et al. reported an electrochemical immunosensor based on screen-printed carbon 
electrodes (SPCE) for the detection of dengue NS1 antigen. Anti-NS1-capturing antibodies 
were immobilized on BSA-modified working electrode of SPCE. The detection was based on 
the measurement of electron transfer resistance before and after the NS1 binding. The study 
demonstrated that the immunosensor successfully detected NS1 antigen with a limit of detec-
tion (LOD) of 0.3 ng/mL and the linear range was 1–200 ng/mL [24]. Pirich et al. worked on 
piezoelectric immunosensor to detect dengue NS1 antigen. For the enhanced binding of anti-
NS1 antibodies, sensor surface was coated with a thin film of bacterial cellulose nanocrystals. 
The formation of antigen antibody complex was then analyzed using quartz crystal microbal-
ance. The study showed that immunochip was able to detect dengue NS1 antigen from serum 
with a LOD of 0.32 μg/mL [25]. In another study, NS1 was detected using Langmuir–Blodgett 
and gold nanoparticles (AuNP) composite as a biosensing surface. The anti-NS1 antibodies 
were immobilized on the biosensing surface and then the sample containing NS1 antigen was 
pipetted on it. Subsequently, the biorecognition event between anti-NS1 antibody and NS1 
antigen was detected through electrochemical impedance spectroscopy. The study showed 
that developed electrochemical immunosensor was capable to detect dengue with a LOD of 
1.19 ng/mL in spiked serum sample [26].
2.1.1.2. Detection of dengue IgM antibodies
Jahanshahi et al. targeted the dengue IgM antibody as an analyte in an optical biosensor. In 
the assay, four serotypes of DENV were used as ligands for capturing IgM antibodies. The 
assay time of optical biosensor was just 10 minutes and required a minimum volume of 1 μl 
of sample to perform it. The sensitivity of developed sensor was ranging from 83 to 93% and 
specificity was 100% [27]. Ortega et al. reported a novel “Magnetic Paper-Based ELISA” for 
New Tools for Dengue Diagnostics
http://dx.doi.org/10.5772/intechopen.81059
133
isotype IgM-dengue antibodies detection. In the assay, magnetite nanoparticles were depos-
ited on cellulose paper sheet. The antihuman IgM-capturing antibodies were immobilized on 
nanoparticle using a cross-linker, namely polydopamine. The concentration of IgM antibod-
ies captured by antihuman IgM antibodies was determined using Bradford assay and SDS gel 
electrophoresis. The study claimed to have 700 times lower LOD than conventional ELISA 
[28]. Ortega et al. reported an electrochemical immunoassay using lead sulfide quantum dots 
as detection label for enhancing the sensitivity of assay by conjugating with anti-IgM detec-
tion antibodies. The immunoassay was performed on ELISA microplate, and electrochemi-
cal response generated by acid dissolution of detection label was measured on SPCE. The 
differential pulse anodic stripping voltammetry was used to measure the electrochemical 
response. Using this technique, immunosensor successfully detected dengue IgM antibod-
ies with a LOD of 130 ng [29]. Wong developed an immunosensor using long-range surface 
plasmon-polariton waveguides for the detection of dengue IgM antibodies. The developed 
immunosensor detected IgM antibodies from a serum sample with a LOD of ∼22 pg/mm2 
[30]. Liu et al. fabricated a label-free immunosensor based on optical fiber long-period grating 
(LPG) for detecting dengue IgM antibodies. For the detection of IgM antibodies, the LPG 
was modified with a film of three layers containing poly(allylamine hydrochloride) and silica 
nanoparticles. Later, anti-IgM antibodies were immobilized via covalent binding on modi-
fied surface. Subsequently, when the sample containing analyte IgM antibodies was added, it 
caused an increase in refractive index of film coated on the surface of LPG leading to a wave-
length shift. This wavelength shift suggested was due to the binding of IgM antibodies with 
anti-IgM antibodies. The optical biosensor developed in this study detected IgM antibodies 
with a detection limit of 15 pg/mm2 [31].
2.1.1.3. Detection of dengue genome
On the other hand, some researchers focused on viral genome as a target analyte in the hunt 
of a point-of-care test. Chan et al. developed a genosensor using a silver nanocluster (Ag NC) 
as hybridization indicator of target DNA with probe DNA. In the assay, the target DNA was 
synthesized from dengue RNA extracted from a mosquito. Afterward, the target DNA was 
hybridized with dengue probe DNA and amplified using isothermal amplification. Following 
the amplification, the product was mixed with AgNO3. Subsequently, the reduction agent NABH
4
 was added to mixture to produce Ag NC which was observed using a UV light. 
This study showed that the developed genosensor could detect DENV genome with a LOD 
of 100 nM [32]. Jin et al. developed an electrochemical genosensor by modifying graphene 
oxide surface with SiO2 particles for enhancing the electrochemical properties of the surface. The negatively charged oligonucleotide primer specific for dengue complementary DNA 
was immobilized on the graphene-oxide-modified surface. Afterward, the sample contain-
ing target complementary DNA was pipetted. It was found that the oligonucleotide primer 
hybridized with complimentary DNA indicating the presence of dengue DNA in the sample. 
EIS was carried out on three electrode cell using PBS solution, and impedance spectra were 
measured. The study claimed to detect dengue DNA with a LOD of 1 femto-molar concentra-
tion of viral genome [33].
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Another genosensor was developed using silicon nanowire to carry out electrochemical-
based assay. First of all, silicon nanowire surface was pretreated for immobilizing the probe 
DNA. Later, the target DNA was added on the surface. The hybridization between probe 
and target DNA was detected through variation in current, conductance, and resistance on 
genosensor because of negative charges which increased with the binding of probe and target 
DNA. The genosensor developed in this study successfully detected DNA with a LOD of 2.0 
fM [34]. Ariffin et al. employed nickel(II) salphen complex as DNA hybridization indicator 
for developing optical genosensor to detect DENV DNA. The indicator was known as a DNA 
intercalating agent. Porous silica nanospheres (PSiNs) were fixed on round plastic supporting 
case as carrier matrix. PSiNs were pretreated with glutaric acid followed by immobilization 
of DNA probe. Subsequently, complementary DNA analyte intercalated with nickel (II) sal-
phen complex was pipetted on PSiNs’ surface. The fiber optic reflectance spectrophotometer 
was used to measure the reflectance intensity of hybridization of target DNA with probe 
DNA. The study demonstrated that genosensor was capable to detect dengue DNA with a 
LOD of 0.2 aM [35].
Multicolor triangular silver nanoparticles (TAgs) were used by Vinayagam et al. as detec-
tion labels for the detection of DENV RNA. TAgs were conjugated with capture probe and 
reporter probe which will hybridize with different regions of target RNA. Later, these capture 
and reporter probes were pooled with analyte RNA, and hybridization was promoted using 
NaCl. The reaction was left for 10 minutes at 37°C. In comparison to non-hybridization, the 
hybridization of probes with target RNA was more stable in the presence of NaCl and, thus, 
develops colors and determines the presence of dengue RNA [36]. Tripathy et al. reported a 
genosensor was based on Manganese (III) Oxide (Mn2O3) nanofibers modified glassy carbon electrode (GCE). The COOH group was introduced on the surface and activated via EDC/NHS 
cross-linker. The capture probe was then immobilized via NH2 group with COOH group 
on GCE. Subsequently, the sample containing target DNA was added, and electrochemical 
responses were measured against a standard calomel reference electrode. The study revealed 
that nanoscale genosensor successfully detected dengue DNA and LOD of the sensor was 
found to be 120 zeptomoles [37]. Rashid et al. worked on electrochemical genosensor that is 
developed on screen-printed gold electrode modified with silicon nanowires (SiNWs). SiNWs 
were deposited on SPGE using various chemical pretreatment. Following the deposition of 
SiNWs, the thiolate DNA probe were immobilized on sensing surface. Subsequently, the 
sample containing target DNA was pipetted to hybridize with probe DNA. The electrochemi-
cal response was measured in the presence of redox indicator using CV and DPV. It was found 
that the developed biosensor was able to detect dengue DNA with a LOD of 1.63 × 10−12 M [38].
2.1.2. RT-LAMP platform
Loop-mediated amplification (LAMP) is a modified version of PCR in which a uniform tem-
perature ranging from 60 to 65°C is applied using a water bath for nucleic acid amplification 
and, thus, obviates the requirement of a thermocycler [39, 40]. This approach to nucleic acid 
amplification relies on strand displacement reaction that produces a self-complementary single- 
stranded loop structure for binding the primers and amplifies target with high specificity 
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and rapidity [41, 42]. The resulting DNA product can be observed by measuring the turbid-
ity produced from the precipitation of by-product magnesium pyrophosphate [43, 44]. In 
addition, the amplification product can be visualized using UV in the presence of fluorescent 
dyes which intercalate in double-strand DNA. The target DNA can be visualized either by 
the naked eyes or quantified by turbidimeter. In comparison to conventional PCR, LAMP is 
highly specific as it employs 4/6 primers that specifically recognize 6/8 distinct sequence of 
target DNA [45, 46]. Sahni et al. developed and evaluated RT-LAMP assay for the detection 
of dengue. In this study, 279 samples including 100 dengue positive, 100 dengue negative, 
and 79 samples from healthy person for negative control were evaluated for testing the sen-
sitivity and specificity of the developed RT-LAMP assay and compared with conventional 
RT-PCR. The study showed that RT-PCR detected dengue in 77 samples while RT-LAMP 
showed good sensitivity and detected dengue in 83 samples. The diagnostic specificity analy-
sis revealed the developed assay did not show any cross-reactivity [47]. In another study, 
a different approach was used to design dengue-specific primers for developing RT-LAMP 
assay. This study exploited a highly conserved dengue NS1 gene which study claimed to 
have >90% sequence similarity among different genotypes within each serotype. The assay 
was single step and carried out in four tubes, each one was specific for distinct dengue sero-
type. For the visualization of RT-LAMP product, Genie® II fluorometer was employed for 
real-time fluorescence detection. The sensitivity of RT-LAMP PCR was compared with CDC 
1-4 real-time PCR. The study showed that the developed RT-LAMP was equally effective in 
discriminating dengue in the acute phase. The limit of detection of this nucleic acid ampli-
fier was found to be 100 copies of viral RNA extracted from each serotype. The specificity 
of RT-LAMP evaluated using the RNA of four closely related Flavivirus is found to be very 
selective [48]. Dauner et al. developed pan-serotype dengue RT-LAMP and investigated the 
sensitivity of RT-LAMP using a panel of clinical samples confirmed by qRT-PCR. The study 
showed that pan-serotype RT-LAMP could discriminate dengue with a sensitivity of 86%. 
This study also visualized the amplification of target gene on lateral flow assay [49]. In one 
study Lau et al. employed hydroxynaphthol blue (HNB) dye for the colorimetric visualiza-
tion of RT-LAMP-amplified product through the naked eye, thus, making the assay simpler 
as it does not require specific tool to interpret the LAMP product. The assay was developed 
in a single tube as multiplex RT-LAMP to detect any of the dengue serotype present in the 
sample. Serotype-specific primers were developed using 3′ noncoding region gene sequences 
for DENV 1–4. The study revealed that RT-LAMP was able to discriminate all four dengue 
serotypes with high sensitivity and short assay time of 45 minutes [50]. Hu et al. reported 
a RT-LAMP technique which employed primers designed from 3′UTR, a highly conserved 
gene in dengue. The 3′UTR sequence of dengue genome was obtained from GenBank, and its 
multiple sequence alignment was achieved using Clustal X. 2.0. In this study, RT-LAMP eval-
uated using mixture of clinical and reference samples containing all four serotypes of dengue. 
It was demonstrated that multiplexed RT-LAMP detected all the four serotypes and showed 
high sensitivity as this method was able to detect as low as 10 copies of viral RNA. In addi-
tion, virus found to be selective as it did not amplify the RNA of any closely related Flavivirus 
when tested with developed multiplexed RT-LAMP [51]. Lopez et al. developed RT-LAMP 
using a novel approach for designing LAMP primers that aimed to match the sequence of 
all circulating dengue virus throughout the world. This study used fast-growing sequence 
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databases having 932 entries of complete dengue genome sequence, and, thus, covered a huge 
diversity reported at that time. A mixture of four final reaction primers was achieved using 
a blend principal component analysis of the full dengue virus genome, and LAMP primers 
were designed through LAVA software. The developed RT-LAMP is found to be selective 
and did not cross-react with other types of Flavivirus. The assay for DENV1 and DENV2 were 
validated using blood and serum samples obtained from different regions [40].
2.1.3. Microfluidic platform
Lab-on-chip (LoC) technology allows the real-time detection of target analyte by integrating 
multiple laboratory process (such as biological sample preparation, processing, and analyz-
ing) on a microprocessor chip into a completely automated and controlled analytical device 
[52–54]. Usually, LoC exploit the microfluidic platform owing to its ability to handle very 
small volume of bodily fluid, less than pico-liters, in micrometer scale channels with dimen-
sions of tens to hundreds of micrometers [55, 56]. In addition, LoC based on microfluidics 
offers several other advantages such as miniaturization, short assay time, portability, user-
friendly, and amenable for multiple detections of target analytes [57, 58]. Since 2000, this 
technology has been widely used in the field of diagnosis for developing a point-of-care test 
[59]. Weng et al. incorporated microfluidic platform with ELISA assay for reducing the detec-
tion time of the assay and lowering the sample volume and developed suction type microflu-
idic immunosensing chip for the identification of DENV. Microfluidic chip designed in this 
study contained a multifunctional micro-transport unit for the transportation and mixing of 
reagents. To reduce nonspecific protein binding polydimethylsiloxane, the material used for 
the fabrication of microfluidic surface was modified. The study demonstrated that microflu-
idic-based immunochip was able to detect dengue using a small volume of 12 μL of dengue 
sample. The developed assay demonstrated high sensitivity with a LOD of 103 PFU/mL and 
short assay time of half an hour and makes more rapid test than ELISA which usually takes 
3–4 hours for detection [60]. Hosseini et al. develop a hybrid platform by combining micro-
sphere and microfluidic disk for the detection of dengue virus. Microspheres were selected as 
they offer large specific surface area, and microspheres designed with functional group were 
integrated into microfluidic disk to promote biorecognition event. For the maximum utiliza-
tion of microspheres’ specific surface area for bimolecular interaction, micromixing system 
was fitted in microfluidic disk. The detection principle of this assay was based on sandwich 
ELISA technique. Utilization of this hybrid platform reduced the long incubation period from 
several hours to 5 minutes and demonstrated high sensitivity by detecting as low as few 
units of dengue virus [61]. Aeinehvand et al. employed centrifugal microfluidic platforms for 
the detection of DENV. Microballoon mixer was introduced that works by its expansion and 
contraction and yields steady periodical reciprocating flow. Implementation of micromixer 
reduced the mixing time of liquids from about 3 hours to 23 s. This study revealed that cen-
trifugal microfluidic platforms developed in this study successfully detected dengue virus 
and shows better sensitivity than traditional ELISA [62]. Thiha et al. miniaturized sandwich 
ELISA method on lab-on-compact disk (LOCD) for the detection of dengue IgG antibody. 
LOCD was established by integrating microfluidic platform on a compact disk-like struc-
ture for performing the entire lab-based procedures, while the centrifugal force of spinning 
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disk was employed for transporting the fluid from one chamber to another. The main reason 
behind choosing this LOCD platform was the low cost, rapid detection, fully automation, and 
multiplex detection of target analytes. In addition, this platform provides high surface area to 
volume ratio and micromixing facility which enhance the biosensing of the assay in terms of 
sensitivity and specificity. After the successful development of the assay, it was evaluated by 
detecting dengue IgG antibody from the several hospitalized patients. The study claimed that 
LOCD successfully detected dengue IgG antibodies with 95% sensitivity and 100% specificity 
[63]. Using the microfluidic dielectrophoresis platform, Iswardy et al. developed a bead-based 
immunofluorescence assay for the detection of dengue virus. During the assay development, 
mouse anti-Flavivirus-capture antibodies were modified with beads, and DENV was modi-
fied with fluorescence label. The principle of this assay was based on employing the DEP to 
capture modified beads in the microfluidic chip which will later interact with modified DENV 
to form immune complex on these beads. Fluorescence microscopy was used to detect fluo-
rescent signals, and later these signals were quantified by Image J freeware. It was found that 
incorporation of microfluidic platform speeds up the immuno-reactions and target analyte 
was detected in a short period of 5 minutes. Interestingly, this assay used ~15 μL of dengue 
sample to test the dengue virus presence. The study showed that the developed assay was 
able to detect DENV with a LOD of 104 PFU/mL [64].
2.1.4. Novel paper-based diagnostic devices
Paper offers several unique advantages than conventional device materials such as power-
free liquid transport through capillary force and evaporation, high surface area to volume 
ratio, and storing reagent in active form within the fiber network [65, 66]. Lo et al. combined 
RT-LAMP with paper-based diagnostic devices for the detection of dengue virus. First, cDNA 
was amplified using RT-LAMP at 63°C. Later, the amplified products were mixed with detec-
tion probes and then moved in paper-based test zone constructed on paper-based diagnostic 
device. Afterwards, the fluorescent signals were examined and analyzed by image recoding 
system and Image J. The developed assay demonstrated high sensitivity in paper-based diag-
nostic device with a LOD of 31.75 μg/mL of amplified products [67]. Zhang et al. worked on 
to improve the flow of salivary fluid in paper-based immunoassay. This study believes that 
paper-based immunoassay is more often compromised due to the formation of aggregates 
between conjugates and specimen and, thus, inhibits the labeled target molecule to reach at 
test line. To resolve this issue, this study developed a stacking flow immunoassay to detect 
dengue-specific IgG antibody in salivary fluid. The stacking flow architecture was aimed to 
bypass the sample pretreatment step which is often required for testing the salivary fluid. 
To achieve this goal, two different paths were designed for guiding the sample and reagents 
separately in the test strip. According to study, application of this tactic prevented the inter-
ference of salivary substances with particle-based sensing system, and these substances were 
omitted before making any contact with the detection reagents, therefore, resulting in low 
background. Moreover, study showed equipping the strip with flow regulator enables the 
uniform flow in the strip which produces even test line. It was found the developed immuno-
assay successfully detected the dengue IgG antibodies which are important biomarker for the 
secondary dengue infection [68]. As we know that low sensitivity is a great disadvantage of 
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lateral flow assay. In one study, Kumar et al. worked on to improve the sensitivity of a paper-
based assay for the detection of NS1 antigen. They exploited tapered nitrocellulose membrane 
and gold decorated graphene oxide sheets as the detection labels for enhancing the sensitivity 
of the assay. The study showed that lateral flow could detect dengue NS1 antigen with a 
LOD of 4.9 ng/mL using this novel format [69]. Theillet et al. developed laser-cut paper-based 
diagnostic device for detecting the dengue NS1 antigens and IgM antibodies. Laser cutting is 
a substitute pattern for producing paper analytical devices (PAD). The important aspect about 
this method is that any layer material could be patterned, irrespective of the fragility or thick-
ness size of the layer. Moreover, the reproducibility pattern using laser cutting is outstanding. 
Laser cutting also provides the facility of modulating fluidics inside the paper channel. The 
purpose of using porous and hydrophilic glass-fiber paper was the motion of fluid specimen 
via passive capillarity. During the assay development, PADs were modified with anti-NS1-
capture antibodies and EDIII antigen to capture the NS1 antigen and dengue-specific IgM 
antibodies, respectively. Later the plasma samples obtained from patients having acute den-
gue were tested on PAD as well as on LFA, for comparing the sensitivity. Detection with this 
type of paper-based device is found to be successful for both NS1 antigen and IgM antibody. 
LOD for the NS1 antigen was 25 ng/mL and it was comparable with commercial LFA [70].
3. Conclusion
In this chapter, we discussed the advanced diagnostic methods for the diagnosis of dengue. In 
terms of analytical sensitivity and rapidity, these novel methods showed remarkable achieve-
ments. However, most of these studies ignored the specificity criteria of diagnostic test. 
Specificity is a very important aspect of diagnostic test which discriminates true negative from 
false positive and true-positive from false-negative detection of an infectious disease. So, this 
aspect should be also investigated along with the sensitivity of the diagnostic test. In addition, 
diagnostic sensitivity and specificity should be also investigated using well-referenced sam-
ples. Moreover, all the four serotypes should be tested to see whether this method is equally 
effective for all serotypes. Testing of these parameters of diagnostic test will give much broad 
picture to analyze its potential for evolving as a point-of-care test.
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